Tate & Lyle PLC (TATE) Receives Consensus Recommendation of “Hold” from Brokerages

Share on StockTwits

Tate & Lyle PLC (LON:TATE) has received a consensus rating of “Hold” from the fourteen research firms that are currently covering the company, MarketBeat reports. One analyst has rated the stock with a sell recommendation, ten have assigned a hold recommendation and three have given a buy recommendation to the company. The average 12 month price objective among brokers that have updated their coverage on the stock in the last year is GBX 702 ($9.17).

Several research firms recently weighed in on TATE. Liberum Capital restated a “buy” rating on shares of Tate & Lyle in a research report on Thursday, September 27th. Deutsche Bank upped their target price on Tate & Lyle from GBX 650 ($8.49) to GBX 675 ($8.82) and gave the stock a “hold” rating in a research note on Friday, November 9th. Credit Suisse Group set a GBX 700 ($9.15) target price on Tate & Lyle and gave the stock a “neutral” rating in a research note on Wednesday, September 19th. Kepler Capital Markets reaffirmed a “reduce” rating on shares of Tate & Lyle in a research note on Thursday, November 8th. Finally, Berenberg Bank upped their target price on Tate & Lyle from GBX 730 ($9.54) to GBX 740 ($9.67) and gave the stock a “hold” rating in a research note on Tuesday.

Shares of TATE stock traded up GBX 9.20 ($0.12) during trading on Monday, hitting GBX 694.80 ($9.08). The company had a trading volume of 1,504,811 shares, compared to its average volume of 2,840,000. Tate & Lyle has a 52 week low of GBX 539.40 ($7.05) and a 52 week high of GBX 796.50 ($10.41).

The company also recently announced a dividend, which will be paid on Friday, January 4th. Shareholders of record on Thursday, November 22nd will be paid a GBX 8.60 ($0.11) dividend. This represents a yield of 1.25%. The ex-dividend date of this dividend is Thursday, November 22nd.

In related news, insider Warren Tucker acquired 4,321 shares of the company’s stock in a transaction dated Wednesday, December 5th. The stock was purchased at an average price of GBX 702 ($9.17) per share, with a total value of £30,333.42 ($39,635.99).

About Tate & Lyle

Tate & Lyle PLC, together with its subsidiaries, provides ingredients and solutions to the food, beverage, and other industries in the United States, the United Kingdom, other European countries, and internationally. It operates through two segments, Speciality Food Ingredients and Bulk Ingredients.

Featured Story: Why investors pay attention to retained earnings

Analyst Recommendations for Tate & Lyle (LON:TATE)

Receive News & Ratings for Tate & Lyle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tate & Lyle and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Columbus McKinnon  versus Lonking  Head to Head Comparison
Columbus McKinnon versus Lonking Head to Head Comparison
Analyzing Insignia Systems  and ANGI Homeservices
Analyzing Insignia Systems and ANGI Homeservices
Tate & Lyle PLC  Receives Consensus Recommendation of “Hold” from Brokerages
Tate & Lyle PLC Receives Consensus Recommendation of “Hold” from Brokerages
Cardinal Health Inc  Receives $60.82 Average Target Price from Brokerages
Cardinal Health Inc Receives $60.82 Average Target Price from Brokerages
Restoration Hardware  Given New $180.00 Price Target at JPMorgan Chase & Co.
Restoration Hardware Given New $180.00 Price Target at JPMorgan Chase & Co.
Proteostasis Therapeutics  Cut to Sell at Zacks Investment Research
Proteostasis Therapeutics Cut to Sell at Zacks Investment Research


Leave a Reply

© 2006-2018 Ticker Report